Philip Forys, MD
Critical Care Medicine · Atlanta, GANPI 1831579770
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (51.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 82.4% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $9,448, more than ten times the $843 reported in 2021. Among critical care medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $200.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Pulmonx Corporation$1K
- Sanofi$216
- AstraZeneca$99
- GSK$79
- Viatris Specialty LLC$75
- plus $300 from 9 others
What the payments were for
- Travel & lodging$3,33831%
- Food & beverage$1,81217%
- Education$5,50052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $8,774 |
| Pulmonx Corporation | 11 | $1,108 |
| Sanofi | 5 | $216 |
| AstraZeneca(2 entities) | 5 | $99 |
| GSK | 4 | $79 |
| Viatris Specialty LLC | 3 | $75 |
| BD | 1 | $55 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Boehringer Ingelheim | 2 | $42 |
| Biogen | 1 | $40 |
| Grifols USA, LLC | 2 | $40 |
| Harmony Biosciences LLC | 1 | $22 |
| Olympus America Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,650 in reported general payments places this provider in the 90th percentile of 265 critical care medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 20 | $264,870 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 189 | $167,308 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 75 | $54,902 |
| Breo ElliptaFluticasone/Vilanterol | 92 | $50,881 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 69 | $33,078 |
| Spiriva RespimatTiotropium Bromide | 37 | $20,207 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 18 | $16,251 |
| MounjaroTirzepatide | 15 | $15,778 |
| SymbicortBudesonide/Formoterol Fumarate | 46 | $13,167 |
| Pirfenidone | 11 | $9,341 |
| Arnuity ElliptaFluticasone Furoate | 29 | $8,595 |
| Advair HfaFluticasone Propion/Salmeterol | 17 | $7,159 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 12 | $6,458 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 35 | $5,140 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 178 | $3,968 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $42 | $301,32975 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $79 | $259,862379 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $99 | $74,527133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 265 critical care medicine providers in Georgia.
Other critical care medicine in Atlanta
- Ramzy RimawiAtlanta$72K
- Matthew SchmittAtlanta$32K
- Jeremy CourtneyAtlanta$8K
- Andre HolderAtlanta$6K
- Michael ConnorAtlanta$4K
- Matthew ThauAtlanta$4K
- Seema TekwaniAtlanta$3K
- Adam WebbAtlanta$3K
- Katie RattrayAtlanta$2K
- Salman FidahusseinLagrange$852K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.